
The Mammotome® Markers portfolio includes a comprehensive set of markers to meet your breast biopsy needs as well as the needs of your patients. Regardless of the type of lesion, breast density, care plan, or sensitivities and preferences of your breast care patients, Mammotome® Markers offer a solution.

Exclusive hydrogel technology provides long-term ultrasound visibility
- Up to 12 months even after neoadjuvant chemotherapy1
- Unique anechoic appearance under ultrasound
- A more visible target for your localization preference2
- Easily seen under MRI during a T2 sequence3


Designed to alleviate surgical displacement, enhance visibility, and ease of locating4-7
- The marker shapes have “wings” that enter the biopsy cavity first and cling to the surrounding breast tissue4
- Enhanced visibility under ultrasound supporting intra-operative localizations5-7
- Offers greater distinguishability under mammography5-6


Rapid collagen expansion for reduced chance of migration8
- Expands rapidly on deployment by 300%8
- Increased surface area improves ultrasound visibility during deployment9
- Quickly absorbs surrounding fluid upon deployment8


Natural non-metal marking alternative for unique patient sensitivities
- Non-animal, non-metallic breast marker designed for patient preference
- Petite gel marker may be selected for biopsies needing a smaller marker or when used with the Mammotome Revolve™ system while in half aperture


Three distinctive, multifaceted 3D shapes designed for easy identification from any angle10
- Self-expanding markers deliver great ultrasound visibility by appearing hyperechoic both immediately and permanently10
- 5mm, 7mm, and 10mm length shapes available


Non-metal biopsy marker alternative with no carrier
- No resorbable composition and a non-animal, non-metallic breast marker designed for patient preferences
- A simple marker offering imaging characteristics in each modality
